Physician profile
Jacquelyn Freeman
NPI 1235596461
$1,119.92
in general payments reported to CMS, 2019-2025
20 companies · $818 in 2025
The $818 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $10.93 · 2024: $291 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $81.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,027.50 |
| Education | $81.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $246.60 | 2024-2025 | |
| Abbvie INC. | $118.65 | 2024-2025 | |
| Pfizer INC. | $100.40 | 2024-2025 | |
| Eisai INC. | $82.00 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $81.49 | 2025 | |
| Lilly USA, LLC | $65.55 | 2024-2025 | Kisunla, Emgality, Amyvid |
| Exact Sciences Corporation | $62.00 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Neurocrine Biosciences, INC. | $58.14 | 2025 | |
| Merz Pharmaceuticals, LLC | $47.84 | 2024 | Xeomin |
| Amgen INC. | $31.46 | 2025 | Uplizna |
| Neurelis, INC. | $31.02 | 2024-2025 | Valtoco |
| Mallinckrodt Hospital Products INC. | $29.91 | 2024 | Acthar |
| Ucb, INC. | $27.23 | 2024 | Rystiggo |
| Genzyme Corporation | $26.24 | 2025 | |
| Alexion Pharmaceuticals, INC. | $23.46 | 2024 | Ultomiris |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| C2n Diagnostics, LLC | $22.17 | 2025 | Precivityad2 |
| Otsuka America Pharmaceutical, INC. | $20.72 | 2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $18.46 | 2024 | Hyqvia |
| Glaxosmithkline, LLC. | $15.65 | 2025 | Trelegy Ellipta |
| Ethicon US, LLC | $10.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacquelyn Freeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.